Intercept Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH

MORRISTOWN, N.J., May 19, 2023 -- Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral... | May 19, 2023

Related Keywords

Karen Preble ,Nareg Sagherian ,Nasdaq ,Linkedin ,Advisory Committee ,Globenewswire Inc ,Gastrointestinal Drugs Advisory Committee ,Intercept Pharmaceuticals Inc ,Drug Administration ,Company On Twitter ,Global Corporate Communications ,Drugs Advisory Committee ,Prescription Drug User Fee Act ,Executive Director ,Global Investor Relations ,Intercept Pharmaceuticals ,Nc Stock Exchange ,News ,Information ,Press Release ,Bay ,023 ,Intercept ,Iopharmaceutical ,Company ,Ocused ,N ,The ,Development ,End ,Ommercialization ,F ,Novel ,Herapeutics ,O ,Treat ,Rogressive Icpt Us45845p1084 ,